Dr. Neil Jay Friedman, MD

Dr. Friedman practices at Midpeninsula Ophthalmology Medical Group Inc in Menlo Park, California.

Dr. Friedman's NPI, 1477644334, was assigned on September 27, 2006. Dr. Friedman graduated from Harvard Medical School in 1992. Dr. Friedman's California license number on file is G084315.

Dr. Friedman's primary practice is Midpeninsula Ophthalmology Medical Group Inc, at 1225 Crane St, Menlo Park, CA 94025 in San Mateo County. The practice phone is (650) 324-0056.

Dr. Friedman's primary practice is Midpeninsula Ophthalmology Medical Group Inc in Menlo Park, California. Dr. Friedman is also affiliated with Stanford Hospital at 300 Pasteur Drive. Dmand AI also links Dr. Friedman to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Friedman practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Friedman's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Friedman is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Friedman's licenses on file in 5 states: California, Arizona, Ohio, Texas and New York.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Friedman treats.

CMS data shows 1,963 Medicare services from Dr. Friedman across 15 procedure codes in 2024, for 758 Medicare patients. Medicare paid $159,255 for them.

CMS counts 758 Medicare patients who saw Dr. Friedman in 2024. The largest group is 75 to 84, with 364 patients. 75% of them have high cholesterol, and 58% have high blood pressure. Their average risk score is 0.88, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Friedman's median patient age at 73, with 56% women.

In 2024, Dr. Friedman wrote 477 Medicare Part D claims for 119 patients. 34% of them were for generic drugs. CMS names the drug for 307 of them, across 11 drugs with 11 or more claims each, at $87,306 in total drug cost. In 2023, CMS named 408 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Friedman for performance year 2024, reported as part of a group. CMS counts 25 procedures of cataract surgery by Dr. Friedman, more than 49% of the clinicians it reports for that procedure.

Dmand AI links 9 papers to Dr. Friedman, published from 2010 to 2020. 2016 was the busiest year, with 2. The most frequent topics are Visual Acuity. Dr. Friedman's most frequent co-authors are Douglas D. Koch, MD, Robert T. Chang, MD and Daniel Youngjun Choi, MD.

CMS Open Payments shows 224 general payments to Dr. Friedman from 25 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 46% of the total. Allergan Inc. paid the most, $17,452.

Dr. Friedman graduated from Harvard Medical School in 1992.

Dr. Friedman is in network with 5 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.